Women in Lymphoma

Educational webinars hosted by Women in Lymphoma are solely intended for professionals working in the field of lymphoma. All patients seeking guidance or support with a lymphoma diagnosis or treatment are advised to consult their specialist haematologist.

_____________________________________________________________________________________________

SERIES 20 - CLL - October/November 2026

Session 1 - Oct 21 - Treatment of CLL in frontline and Role of MRD Measurement - Meghan Thompson, Lydia Scarfo

Session 2 - Oct 28 - Refractory disease and management of treatment associated side effects - Inhye Ahn, Tamar Tadmor

Session 3 - Nov 4 - TRichter Transformation: Diagnostics and Treatment - Adalgisa Condoluci, Anna-Maria Frustaci

Session 4 - Nov 11 - Challenges in CLL- Marta Coscia, Ruth Clifford

Session 5 - Nov 18 - Discussion around career development - Jennifer Brown, Deborah Stephens, Ellinor Goergen, Sabrina Kersting, Mary Ann Anderson

SERIES 19 - Japanese Experts Series - September 2026

Session 1 - Sep 2 - Emerging therapeutic strategies for EBV-associated T/NK-cell neoplasms - Dr Miki Ando, Dr Ayako Arai

Session 2 - Sep 9 - Challenges in understanding and treating ENKTL and ANKL - Dr Motoko Yamaguchi, Dr Ayumi Fuijmoto

Session 3 - Sep 16 - Tumor microenvironment analysis and novel therapeutic development in T/NK-cell neoplasms - Dr Mamiko Sakata-Yanagimoto, Dr Ai Kotani

Session 4 - Sep 23 - Therapeutic Strategies Targeting Cellular Interactions in B-cell Lymphoma and ATL - Dr Momoko Nishikori, Dr Youko Suehiro

Session 5 - Sep 30 - Publishing in Hematology & Oncology: How to Get Your Work Accepted - Dr Aya Takemoto Tokaji

SERIES 18 - LATAM Series (the session will be in Spanish language) - May/Jun 2026

Session 1 - May 6 - Dificultades en diagnóstico en linfomas no Hodgkin: ¿Qué es necesario y relevante en la práctica clínica? - Marcela de Dios Soler, Leticia Quintanilla. Recording

Session 2 - May 13 - Linfoma Difuso de Células B Grandes (DLBCL): Innovación y Acceso - Anna Sureda, Carolina Mahuad. Recording

Session 3 - May 20 - LLC: De la Biologia a la Práctica Clinica. Nuevos Modelos de Resistencia Molecular y su Impacto Terapéutico - Romina Gamberale, Carolina Oliver. Recording

Session 4 - May 27 - Terapias Celulares en Linfoma De la investigación local al CAR-T: producción, regulación y experiencia regional - Gloria Iacoboni, Beatriz Wills, Sofia Grille. Recording

Session 5 - Jun 3 - Linfoma de Hodgkin: Innovación terapéutica, supervivencia y equidad - Carla Casulo, Astrid Pavlovsky. Recording

SERIES 17 - DLBCL - Feb/Mar 2026

Session 1 - Feb 11 - DLBCL in Elderly - Pallawi Torka, Emily Ayers. Recording

Session 2 - Feb 18 - Bispecifics in DLBCL - Jennifer Crombie, Eliza Hawkes. Recording

Session 3 - Feb 25 - Secondary CNS Lymphoma - Diva Baggio, Laskhmi Nayak. Recording.

Session 4 - Mar 4 - Circulating Tumor DNA in Large B cell Lymphoma - Martine Chamuleau, Sirpa Leppa. Recording

SERIES 16 - Mantle Cell Lymphoma - Oct/Nov 2025

Session 1 - Recent updates for frontline therapy of MCL - Maria Gomes da Silva, Christine Ryan. recording

Session 2 - Recent updates in high risk MCL - Anita Kumar, Morgane Cheminant. recording

Session 3 - Recent updates in relapsed/refractory MCL including novel agents - Eva Giné, Clémentine Sarkozy. recording

Session 4 - Recent updates on the role of MRD in MCL - Christiane Pott, Aurore Touzart. recording

SERIES 15 - PATHOGENS AND LYMPHOMA - July 2025

Session 1 - EBV and lymphomagenesis - Marie Donzel, Jennifer Amengual. recording

Session 2 - Microbiome in lymphomas - Catherine Diefenbach, Paola Ghione. recording

Session 3 - Do infectious agents drive lymphoma initiation? - Catherine Thieblemont, Ayako Arai. recording

Session 4 - Post-treatment risk for infection - Swetha Thiruvengadam, Sairah Ahmed, Mini Kamboj. recording

SERIES 14 - DEMYSTIFYING PHARMA - Apr/May 2025

Session 1 - Pharma Structure - Michelle Dawson, Nina Shah. recording

Session 2 - Industry Engagement - Clare Spooner, John Wahba, Suhaida Selamat. recording

Session 3 - Successful Research Collaboration - Julia Brain, Candice McCoy. recording

Session 4 - Careers in Pharma - Connie Batlevi, Jamie Hirata. recording

SERIES 13 - INDOLENT LYMPHOMA - Oct/Nov 2024

Session 1 - First step of lymphomagenesis (t14;18 & CREBBP) - Dr. Sandrine Roulland & The CPC in its niche - Dr. Karin Tarte. recording

Session 2 - Biological Determinants of Progression and Transformation of Follicular Lymphoma - Prof. Jess Okosun & Risk stratification versus genomic classification in FL - Carla Casulo, MD. recording

Session 3 - First line for LTB & HTB - Dr Clémentine Sarkozy & RELEVANCE and preliminary data on PET as a biomarker, including its combination with ctDNA, recent advances in radiomics - Dr Anne-Ségolène Cottereau. recording

Session 4 - DEBATE : High risk relapsed FL should be treated differently. FOR – Dr Kim Linton & AGAINST – Dr Astrid Pavlovsky. recording

Session 5 - Career Development. recording

SERIES 12 - HODGKIN LYMPHOMA - May/June 2024

Session 1 - Strategies to Tailor Treatment for Hodgkin Lymphoma. recording

Session 2 - Global Perspectives on Treatment of Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma with a Focus on Advanced Stage. recording

Session 3 - Current/Forthcoming Clinical Trials in Hodgkin Lymphoma. recording

Session 4 - Nodular Lymphoma Predominant Hodgkin Lymphoma and Other Pathologic Phenomena in Hodgkin Lymphoma. recording

SERIES 11 – DLBCL - March/April 2024

Session 1 - Upfront DLBCL Therapy. recording

Session 2 - The Changing Algorithm in R/R DLBCL. recording

Session 3 - Expanding Novel Therapies in R/R DLBCL. recording

Session 4 - Tailoring Therapy in R/R DLBCL. recording

Session 5 - Update on DLBCL Classification. recording

SERIES 10 – CAREER DEVELOPMENT - Oct/Nov 2023

Session 1 - Navigating early career development: Mentorship and Academic Promotion. recording

Session 2 - Tips & Pearls for Publishing Success. recording

Session 3 - Identifying and Pursuing Research Opportunities and Cooperative work. recording

Session 4 - Making Meaning in the Second half of your Career – leadership planning and new experiences. recording

SERIES 9 – MANTLE CELL LYMPHOMA (MCL) - May 2023

Session 1 - MCL Treatment. recording

Session 2 - MCL Prognostication. recording

Session 3 - Pathogenesis & Biology. recording

SERIES 8 – CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) - Feb/Mar 2023

Session 1 - CLL frontline treatment/new drugs/global access. recording

Session 2 - Tough CLL. recording

Session 3 - Career Development. recording

Session 4 - Optimal Investigation of CLL - molecular studies, risk stratification & MRD. recording

SERIES 7 - LYMPHOMA & THE BRAIN - Sept/Oct 2022

Session 1 - PCSNL - Diagnosis and Treatment. recording

Session 2 - PSNSL - Elderly and side effects. recording

Session 3 - SCNSL and CAR-T. recording

Session 4 - Debate on CNS Prophylaxis. recording

Session 5 - Other brain lymphomas & imaging. recording

SERIES 6 - CELLULAR THERAPY - Apr/May 2022

Session 1- Defining Cellular Therapies. recording

Session 2 - CAR-T Cells in different clinical settings - Treatment of DLBCL/Treatment of FL, MCL, CLL. recording

Session 3 - Moving forward in CAR-T Cell - Mechanisms of Resistance/Modified CAR-T Strategies – Allo CAR-T, Dual CAR-T. recording

Session 4 - CAR-T Strategies vs. BiTes. recording

Session 5 - Global discussion on access, application, real-life experiences & challenges. recording

SERIES 5 - CAREER DEVELOPMENT - Mar/Apr 2022

Session 1 - APPs. recording

Session 2 - Legendary WiL. recording

SERIES 4 – INDOLENT LYMPHOMA - Oct/Nov 2021

Session 1 - Living with Follicular Lymphoma/Follicular Lymphoma pathogenesis and clonal evolution, transformed FL. recording

Session 2 - Risk stratification in Follicular Lymphoma/Utility of PET in Follicular Lymphoma. recording

Session 3 - Advances for treatment for Follicular Lymphoma/Treatment paradigms for relapsed and refractory Follicular Lymphoma. recording

Session 4A - Career Development with Change Champions and their Mentees. recording

Session 4B - Career Development with Change Champions and their Mentees. recording

Session 5 - Treatment options in Marginal Zone Lymphoma/Waldenstrom’s Macroglobulinemia. recording

SERIES 3 - T-CELL LYMPHOMA - Apr/May 2021

Session 1- Update on T-cell: Lymphoma HemPath review/Primary therapy of common peripheral T-cell lymphoma. recording

Session 2 - HemPath review of T-cell lymphomas common in Asia/Frontline & Salvage therapies for T-cell lymphomas common in Asia. recording

Session 3 - Treatment & outcome for relapsed T-cell lymphomas/Use of autologous & allogenuc transplant for T-cell lymphomas. recording

Session 4 - Newer therapies & Clinical trials for T-cell lymphomas/Case studies of T-cell lymphomas. recording

Session 5 - Career Development. recording

SERIES 2 - HODGKIN LYMPHOMA - Jan/Feb 2021

Session 1 - Harnessing The Immune System To Treat Hodgkin Lymphoma. recording

Session 2 - Radiation In HL: A Showcase Of An Ideal Therapeutic Ratio. recording

Session 3 - Optimising The Care Of Aya Hodgkin Lymphoma. recording

Session 4 - Hodgkin Lymphoma Cases: A Global Discussion. recording

Session 5 - Career Reflections. recording

SERIES 1 - DLBCL - Sept 2020

Unfortunately recordings are not available for this series.

Session 1 - How I Approach Newly Diagnosed DLBCL

Session 2 - How I manage relapsed DLBCL

Session 3 - PET-pearls & PET-pitfalls in DLBCL

Session 4 - DLBCL: Lessons learnt from LYSA clinical trials

Session 5 - CNS Prophylaxis in Diffuse Large B Cell Lymphoma

Where there's a WiL, there's a way

WiLing Wednesdays Education Webinars